0001438133-24-000011.txt : 20240220 0001438133-24-000011.hdr.sgml : 20240220 20240220192631 ACCESSION NUMBER: 0001438133-24-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240215 FILED AS OF DATE: 20240220 DATE AS OF CHANGE: 20240220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sheridan John F CENTRAL INDEX KEY: 0001365369 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36189 FILM NUMBER: 24655824 MAIL ADDRESS: STREET 1: C/O TANDEM DIABETES CARE, INC. STREET 2: 11045 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE CITY: San Diego STATE: CA ZIP: 92130 4 1 wk-form4_1708475167.xml FORM 4 X0508 4 2024-02-15 0 0001438133 TANDEM DIABETES CARE INC TNDM 0001365369 Sheridan John F 12400 HIGH BLUFF DRIVE SAN DIEGO CA 92130 1 1 0 0 PRESIDENT & CEO 0 Common Stock 2024-02-15 4 M 0 793 0 A 28368 D Common Stock 2024-02-15 4 F 0 325 24.29 D 28043 D Common Stock 2024-02-15 4 M 0 2236 0 A 30279 D Common Stock 2024-02-15 4 F 0 917 24.29 D 29362 D Restricted Stock Unit 2024-02-15 4 M 0 793 0 D Common Stock 793 3962 D Restricted Stock Unit 2024-02-15 4 M 0 2236 0 D Common Stock 2236 11182 D Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Awarded on May 25, 2022 pursuant to the 2013 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. /s/ Rachel Malina, Attorney-in-Fact for John F. Sheridan 2024-02-20